An Industry Perspective on the Future Changes in Pharmacovigilance and Safety Assessment for IND Reporting

In December 2015, FDA released a draft guidance on safety assessment for IND safety reporting in support of the changes in the IND safety reporting regulations. These recommendations have presented challenges for many organizations and this webinar will give a perspective from a company that has worked with FDA to implement the key elements of the guidance.